Industry

CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA®) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and the use … [Read more…]

France’s leading healthcare provider chooses HPE GreenLake edge-to-cloud platform for its Certified Cloud Offering PARIS–(BUSINESS WIRE)–Hewlett Packard Enterprise (NYSE: HPE) today announced that leading French healthcare software provider, Maincare has adopted the HPE GreenLake to power its highly secure cloud offering, Maincare Hosting Services. Maincare will use HPE Synergy, HPE’s software-defined composable infrastructure, in an … [Read more…]

HORSHAM, Pa.–(BUSINESS WIRE)–Myonex, a leading global clinical trial supply company, announces the launch of the first and only on-demand local drug sourcing in Europe. Built on a successful North American program, CTRx Europe offers significant benefits for trial sponsors, sites, and patients alike. “With the growth of our CTRx service in North America, clients have … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trial IT Solutions Market, 2022: Frost Radar Report” report has been added to ResearchAndMarkets.com’s offering. To improve clinical trial efficiency, pharma companies are turning towards cloud-based electronic data capture (EDC), randomization and trial supply management (RTSM), and integrated platforms that offer them a unified trial workflow view. Major companies are exploring … [Read more…]

Simcere will receive a $15 million upfront payment and up to US$492 million in development and commercial milestone payments considering successful achievements in several indications, with an important part as sales milestones, as well as up to low double-digit tiered royalties based upon future global sales Under the agreement, Almirall will be granted an exclusive … [Read more…]

Digital-first healthcare company grows leadership team to continue to amplify its presence in key markets. AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced the hiring of Andrew Hine as Vice President of the Go-to-Market team. Hine joins Babylon’s Go-to-Market leadership team from Ernst & Young. In this role, Hine will lead the company’s sales … [Read more…]

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that management will participate in the following upcoming events in October: Investors’ Day Geneva  October 5, 2022  Geneva, Switzerland  Dave Marver, … [Read more…]

LEO Pharma and DKSH have entered into an agreement to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia. This agreement both supports LEO Pharma’s strategy of building a simpler and more competitive organization and DKSH Business Unit Healthcare’s strategic focus of strengthening its regional footprint. BALLERUP, Denmark & BANGKOK, Thailand–(BUSINESS WIRE)–DKSH … [Read more…]

Appointment Strengthens Sales Operating Model To Accelerate Growth, Increase Productivity, and Intensify Focus on Key Markets SAN FRANCISCO–(BUSINESS WIRE)–Healthcare technology company Komodo Health today announced that Lauren Stahl has been appointed as the company’s Vice President and Head of Sales, effective immediately. In this capacity, Stahl’s responsibilities include sales team leadership across Komodo’s entire portfolio … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat cancer, today announced the publication of a study in the New England Journal of Medicine entitled “GPRC5D-Targeted CAR T Cells for Myeloma.” The study was led by Dr. Eric Smith of the Dana-Farber Cancer Institute, Dr. Renier Brentjens of … [Read more…]